insights_auto
Why is ORX down 23,39%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
1,05 SEK
arrow_downward
-23,39%(-0,32) 1D
9 қар., 17:29:41 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,03 SEK
High
1,25 SEK
Low
0,99 SEK
Mkt. cap
36,76 млн
Avg. vol.
337,59 м.
Volume
1,28 млн
P/E ratio
0,05
52-wk high
36,00 SEK
52-wk low
0,99 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,03 SEK
High
1,25 SEK
Low
0,99 SEK
Mkt. cap
36,76 млн
Avg. vol.
337,59 м.
Volume
1,28 млн
P/E ratio
0,05
52-wk high
36,00 SEK
52-wk low
0,99 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
Bloomberg.com
·
5 сағат бұрын
Watch S&P 500 Erases Midterm Losses, Bitcoin Bounce
Investing.com
·
5 сағат бұрын
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.15%
TradingView
·
9 сағат бұрын
QUICK SPARK: Nvidia Stock Eyes Worst Day Against S&P 500 Since DeepSeek's Shock
24/7 Wall St.
·
7 сағат бұрын
Verizon’s Dividends Kept $1,000 Afloat at $1,580 While the S&P 500 Reached $3,910
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com